The global Blood Transfusion Device Market size was estimated at USD 5,283.74 million in 2025 and is expected to reach USD 7,757.84 million by 2032, growing at a CAGR of 5.64% from 2025 to 2032. Growth is primarily supported by rising transfusion-linked clinical workloads across surgery, trauma, oncology, and chronic disease management, which increases the recurring need for safe collection, processing, storage, and administration tools in hospitals and blood centers. Ongoing modernization of transfusion workflows, including higher automation in component preparation and stronger safety and traceability practices, continues to reinforce replacement demand and pull-through for consumables across mature markets and rapidly expanding healthcare systems.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2024
Base Year
2025
Forecast Period
2026-2032
Blood Transfusion Device Market Size 2025
USD 5,283.74 million
Blood Transfusion Device Market, CAGR
5.64%
Blood Transfusion Device Market Size 2032
USD 7,757.84 million
Key Market Trends & Insights
The Blood Transfusion Device Market is projected to increase from USD 5,283.74 million in 2025 to USD 7,757.84 million by 2032, reflecting sustained demand expansion through the forecast window.
The market is expected to grow at a CAGR of 5.64% during 2025–2032, supported by steady procedure volumes and ongoing workflow modernization in transfusion services.
Blood bags & accessories accounted for the largest product share of 37.4% in 2025, reflecting high-frequency consumable usage across routine collection and transfusion pathways.
Blood Collection represented 42.3% of the application mix in 2025, supported by structural repeat volumes and standardized donation and hospital draw protocols.
North America held the leading regional share of 39.3% in 2025, supported by mature blood center networks and higher per-procedure device intensity.
Segment Analysis
Demand patterns in the Blood Transfusion Device Market are shaped by recurring consumables and the reliability requirements of transfusion workflows, which sustain purchasing across hospitals and blood centers. Buyers typically prioritize safety, standardization, and compatibility with established processing and administration practices, which favors suppliers offering integrated portfolios spanning collection sets, component preparation, storage consumables, and access devices. Automation is increasingly evaluated through productivity and error-reduction lenses, particularly in high-throughput blood centers that seek consistent component quality and reduced manual handling.
Procurement decisions also reflect a shift toward workflow simplification and traceability, with more emphasis on closed-system handling, labeling discipline, and inventory management to reduce wastage and improve availability. In parallel, hospitals and specialty care settings continue to value dependable transfusion administration and access solutions that can reduce variability across clinical teams. Across regions, the mix of replacement demand and capacity expansion creates a balanced growth profile, with faster adoption of modern systems where healthcare infrastructure is scaling.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Blood bags & accessories accounted for the largest share of 37.4% in 2025. The segment leads because blood bags, tubing, and related consumables are used repeatedly across routine donation, component separation, and bedside administration workflows, creating high-volume pull-through. Standardized configurations and strict quality requirements reinforce consistent procurement and predictable replacement cycles. The large installed base of collection and processing systems further supports steady consumable demand across both hospitals and blood centers.
By Application Insights
Blood Collection accounted for the largest share of 42.3% in 2025. Collection remains the highest-throughput stage because every downstream activity depends on reliable upfront blood draw and donation operations. Standard donation protocols, continuous donor engagement programs, and routine inpatient and outpatient phlebotomy volumes reinforce repeat use of collection sets and associated consumables. Providers also prefer products that improve speed and consistency, which supports adoption of user-friendly collection solutions in high-turnover settings.
By End User Insights
Hospitals accounted for the largest share of 46.8% in 2025. Hospitals lead because transfusion activity is closely tied to surgical procedures, trauma management, oncology care, and critical care pathways that require reliable access and administration readiness. Centralized procurement and protocol-driven transfusion services increase standardization of devices and consumables, supporting higher per-facility purchasing volumes. Hospitals also drive upgrades toward safer and more efficient workflows as they seek to reduce errors and improve component utilization.
Blood Transfusion Device Market Drivers
Rising transfusion-linked clinical workload across hospitals and specialty care
Clinical demand for transfusion support is sustained by procedure-intensive care pathways such as complex surgeries, trauma stabilization, oncology supportive care, and chronic anemia management. These settings require reliable availability of collection, processing, storage, and administration devices with consistent performance. Hospitals typically standardize transfusion protocols, which reinforces repeat demand for validated consumables and compatible accessories. As case volumes rise and clinical teams seek consistency, purchasing increasingly favors dependable products with established quality and supply continuity.
Ongoing modernization and automation of blood center processing workflows
Blood centers and high-volume hospital transfusion services continue to modernize component preparation to improve productivity and reduce manual variability. Automation and integrated processing systems are adopted to standardize yields, lower handling steps, and support consistent component quality. These investments typically increase pull-through for proprietary disposables and validated consumables tied to the installed base. Over time, modernization programs also accelerate replacement cycles as facilities upgrade legacy equipment to meet operational and compliance expectations.
For instance, Terumo BCT reports that its Reveos system can separate 12 whole blood units into red blood cells, platelets, and plasma up to 24 minutes faster than semi-automated buffy coat processing, reduce hands-on steps by up to 65%, and scale to about 72,000 units annually with one operator using four devices.
Increasing emphasis on safety, standardization, and traceability in transfusion practice
Transfusion pathways are quality-sensitive, driving stronger emphasis on standardized devices and consumables that reduce process variability and support reliable documentation. Providers increasingly value closed or controlled handling systems, consistent labeling practices, and inventory discipline to reduce wastage and improve component availability. These requirements strengthen demand for compatible device ecosystems spanning collection, processing, and administration. Safety-driven procurement also supports adoption of improved access and collection solutions that lower risk and support consistent clinical execution.
For instance, Haemonetics says its BloodTrack Tx software uses 2D barcode technology each time a specimen is collected, a product is requested, or a transfusion occurs, while its BloodTrack OnDemand with HaemoBank is positioned as a 24/7 virtual automated transfusion service to strengthen bedside verification and traceability.
Expanding healthcare capacity and access to surgical care in developing markets
In many developing markets, healthcare expansion increases the volume of surgeries and acute care services that require transfusion readiness, raising demand for both equipment and consumables. As blood banking infrastructure improves, procurement extends beyond basic supplies into more standardized processing and storage workflows. Public and private investments in hospital capacity also encourage the adoption of reliable transfusion-support devices aligned with modern protocols. This capacity-driven growth supports steady market expansion alongside mature-market replacement demand.
Blood Transfusion Device Market Challenges
Operational constraints remain a key barrier in transfusion workflows because blood collection and processing require trained staff, strict procedures, and reliable cold-chain handling. Shortages of skilled personnel can limit throughput and reduce the effective utilization of advanced processing systems, especially in smaller facilities. Budget constraints also slow replacement cycles when institutions prioritize immediate clinical needs over infrastructure modernization. Inconsistent donor supply patterns and collection logistics can further disrupt utilization planning and inventory stability.
Regulatory and quality compliance requirements create complexity for manufacturers and providers due to validation needs, documentation expectations, and traceability discipline across the transfusion chain. Hospitals and blood centers must maintain consistent quality controls, which can increase procurement scrutiny and lengthen product adoption timelines. Product standardization can also create switching friction because facilities prefer compatibility with established installed bases. Supply chain variability for specialized consumables can introduce procurement risk and encourage multi-sourcing strategies.
For instance, Cerus’ INTERCEPT Blood System for Platelets has demonstrated more than 5.7 log10 reduction of viable T-cells, more than 6.3 log10 reduction for dengue virus in platelets suspended in plasma/additive solution, and more than 7.2 log10 reduction for Escherichia coli, while supporting platelet storage for up to 7 days at 20-24°C with continuous agitation.
Blood Transfusion Device Market Trends and Opportunities
Automation adoption continues to expand as blood centers and large hospitals pursue productivity gains and more consistent component preparation outputs. Facilities increasingly evaluate solutions that reduce manual handling, improve process standardization, and support repeatable quality performance at scale. This trend creates opportunities for integrated platforms that combine processing steps and strengthen workflow efficiency. Vendors that align offerings with operational metrics, training support, and service reliability can improve adoption in high-throughput settings.
For instance, Terumo Blood and Cell Technologies states that its Reveos Automated Blood Processing System is the first whole-blood automation device commercially available in the U.S. to process whole blood into platelets and other components in a single centrifugation cycle, and the platform can process up to four whole-blood units in a single run; the company has also reported deployment of the system in 52 countries over the past decade, underscoring its relevance for high-throughput component labs.
Improved traceability and inventory management practices are gaining attention as providers seek to reduce component wastage and improve availability across transfusion services. Opportunities are emerging for solutions that support better tracking, standardized documentation, and smoother coordination across collection, processing, storage, and administration. Markets with expanding healthcare capacity also present growth pathways for scalable and standardized transfusion-support kits and accessories. Product designs that simplify clinician workflows and improve ease-of-use can strengthen differentiation in competitive tenders.
Regional Insights
North America
North America held 39.3% share in 2025, supported by mature blood center networks, high surgical volumes, and structured transfusion services in hospitals. Procurement in the region emphasizes safety, standardization, and compatibility with established processing and administration workflows. Replacement cycles are supported by continuous quality expectations and demand for operational efficiency in component preparation. Strong service infrastructure and consistent supply requirements favor vendors with reliable installed-base support and consumable availability.
Europe
Europe accounted for 28.1% share in 2025, supported by established healthcare systems and stringent blood safety and quality expectations. Facilities typically prioritize standardized component preparation, controlled handling, and reliable storage practices that support consistent quality outcomes. Replacement demand remains steady as institutions modernize transfusion services and improve workflow efficiency. Regional procurement often favors proven products and supplier credibility in quality assurance and long-term service support.
Asia Pacific
Asia Pacific captured 24.8% share in 2025, supported by expanding hospital capacity and growing adoption of standardized transfusion practices. Rising procedure volumes and strengthening blood bank infrastructure increase demand for collection, processing, and storage solutions. Investment in healthcare modernization supports uptake of more efficient systems in higher-volume centers, even as many facilities continue to scale from basic capabilities. Vendors that offer scalable product portfolios and training support are positioned to benefit from capacity-driven growth.
Latin America
Latin America represented 5.2% share in 2025, with demand shaped by gradual improvements in hospital infrastructure and transfusion service capabilities. Procurement often focuses on dependable consumables and essential equipment that supports consistent collection and administration. Market growth is influenced by capacity expansion, upgrades in blood bank practices, and wider adoption of standardized protocols. Supply reliability and cost effectiveness remain important selection factors for many buyers.
Middle East & Africa
Middle East & Africa held 2.6% share in 2025, reflecting uneven infrastructure maturity and varied blood banking capacity across countries. Demand is supported by selected investments in hospital expansion and improvements in transfusion readiness in tertiary care settings. Procurement typically concentrates on core collection, storage, and administration needs, with gradual movement toward standardized workflows where capacity allows. Long-term growth depends on broader infrastructure development, workforce capability, and consistent supply availability.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Competition in the Blood Transfusion Device Market is driven by breadth of portfolio coverage across collection, processing, storage, and administration workflows, along with the ability to support reliability and standardization in high-throughput settings. Suppliers differentiate through integrated system offerings, consumable pull-through ecosystems, service and training support, and compatibility with established clinical protocols. Product design improvements that reduce handling steps, support traceability discipline, and improve ease-of-use help strengthen positioning in institutional procurement. Scale, quality assurance credibility, and supply continuity remain decisive factors in competitive tenders.
Fresenius Kabi / Fresenius SE & Co. KGaA is positioned as a broad healthcare supplier with strengths in transfusion-adjacent products and hospital-facing procurement channels, enabling cross-sell across related clinical workflows. The company’s approach typically emphasizes standardized, quality-aligned solutions that fit established hospital processes and support reliable clinical execution. Scale in manufacturing and distribution supports continuity for high-frequency consumables and accessories. This positioning aligns with buyer priorities for dependable supply, consistent product performance, and reduced operational disruption in transfusion services.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Developments
In March 2025, Grifols signed a strategic agreement with Inpeco to provide transfusion medicine laboratories with integrated instrumentation, robotics, and software to modernize workflows and improve efficiency.
In June 2024, Innobiochips introduced Omnys, an advanced blood transfusion device designed to improve laboratory productivity and accuracy through multiplex analysis, including ABO/D typing and extended phenotyping. The company said the system helps streamline testing, reduce the number of wells required, and minimize waste in transfusion laboratories
Report Scope
Report Attribute
Details
Market size value in 2025
USD 5283.74 million
Revenue forecast in 2032
USD 7757.84 million
Growth rate (CAGR)
5.64% (2025–2032)
Base year
2025
Forecast period
2026-2032
Quantitative units
USD million
Segments covered
By Product Type; By Application; By End User
Regional scope
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Key companies profiled
17 companies
No.of Pages
326
Segmentation
By Product Type
Pathogen reduction systems
Apheresis devices
Blood component separators
Blood bags and accessories
Venous access devices
Autotransfusion systems, consumables, and accessories
By Application
Blood Collection
Blood Processing
Blood Storage
Blood Transfusion
By End User
Hospitals
Blood banks / blood centers
Ambulatory surgical centers / specialty clinics
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
1. Introduction
1.1. Report Description
1.2. Purpose of the Report
1.3. USP & Key Offerings
1.4. Key Benefits for Stakeholders
1.5. Target Audience
1.6. Report Scope
1.7. Regional Scope 2. Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology 3. Executive Summary 4. Introduction
4.1. Overview
4.2. Key Industry Trends 5. Global Blood Transfusion Device Market
5.1. Market Overview
5.2. Market Performance
5.3. Impact of COVID-19
5.4. Market Forecast 6. Market Breakup by Product Type
6.1. Pathogen Reduction Systems
6.1.1. Market Trends
6.1.2. Market Forecast
6.1.3. Revenue Share
6.1.4. Revenue Growth Opportunity
6.2. Apheresis Devices
6.2.1. Market Trends
6.2.2. Market Forecast
6.2.3. Revenue Share
6.2.4. Revenue Growth Opportunity
6.3. Blood Component Separators
6.3.1. Market Trends
6.3.2. Market Forecast
6.3.3. Revenue Share
6.3.4. Revenue Growth Opportunity
6.4. Blood Bags and Accessories
6.4.1. Market Trends
6.4.2. Market Forecast
6.4.3. Revenue Share
6.4.4. Revenue Growth Opportunity
6.5. Venous Access Devices
6.5.1. Market Trends
6.5.2. Market Forecast
6.5.3. Revenue Share
6.5.4. Revenue Growth Opportunity
6.6. Autotransfusion Systems, Consumables, and Accessories
6.6.1. Market Trends
6.6.2. Market Forecast
6.6.3. Revenue Share
6.6.4. Revenue Growth Opportunity 7. Market Breakup by Application
7.1. Blood Collection
7.1.1. Market Trends
7.1.2. Market Forecast
7.1.3. Revenue Share
7.1.4. Revenue Growth Opportunity
7.2. Blood Processing
7.2.1. Market Trends
7.2.2. Market Forecast
7.2.3. Revenue Share
7.2.4. Revenue Growth Opportunity
7.3. Blood Storage
7.3.1. Market Trends
7.3.2. Market Forecast
7.3.3. Revenue Share
7.3.4. Revenue Growth Opportunity
7.4. Blood Transfusion
7.4.1. Market Trends
7.4.2. Market Forecast
7.4.3. Revenue Share
7.4.4. Revenue Growth Opportunity 8. Market Breakup by End User
8.1. Hospitals
8.1.1. Market Trends
8.1.2. Market Forecast
8.1.3. Revenue Share
8.1.4. Revenue Growth Opportunity
8.2. Blood Banks / Blood Centers
8.2.1. Market Trends
8.2.2. Market Forecast
8.2.3. Revenue Share
8.2.4. Revenue Growth Opportunity
8.3. Ambulatory Surgical Centers / Specialty Clinics
8.3.1. Market Trends
8.3.2. Market Forecast
8.3.3. Revenue Share
8.3.4. Revenue Growth Opportunity 9. Market Breakup by Region
9.1. North America
9.1.1. United States
9.1.1.1. Market Trends
9.1.1.2. Market Forecast
9.1.2. Canada
9.1.2.1. Market Trends
9.1.2.2. Market Forecast
9.2. Asia-Pacific
9.2.1. China
9.2.2. Japan
9.2.3. India
9.2.4. South Korea
9.2.5. Australia
9.2.6. Indonesia
9.2.7. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Others
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Others
9.5. Middle East and Africa
9.5.1. Market Trends
9.5.2. Market Breakup by Country
9.5.3. Market Forecast 10. SWOT Analysis
10.1. Overview
10.2. Strengths
10.3. Weaknesses
10.4. Opportunities
10.5. Threats 11. Value Chain Analysis 12. Porters Five Forces Analysis
12.1. Overview
12.2. Bargaining Power of Buyers
12.3. Bargaining Power of Suppliers
12.4. Degree of Competition
12.5. Threat of New Entrants
12.6. Threat of Substitutes 13. Price Analysis 14. Competitive Landscape
14.1. Market Structure
14.2. Key Players
14.3. Profiles of Key Players
14.3.1. Fresenius Kabi / Fresenius SE & Co. KGaA
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. Financials
14.3.1.4. SWOT Analysis
14.3.2. Grifols, S.A.
14.3.3. Terumo Corporation
14.3.4. Immucor, Inc.
14.3.5. B. Braun Melsungen AG
14.3.6. BD (Becton, Dickinson and Company)
14.3.7. Haemonetics Corporation
14.3.8. Teleflex Incorporated
14.3.9. Medtronic
14.3.10. LivaNova PLC
14.3.11. Redax
14.3.12. Baxter International Inc.
14.3.13. Kawasumi Laboratories, Inc.
14.3.14. Kaneka Corporation
14.3.15. Macopharma SA
14.3.16. 3M Company 15. Research Methodology
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the market size of the Blood Transfusion Device Market in 2025 and the forecast for 2032?
The market was valued at USD 5,283.74 million in 2025. It is projected to reach USD 7,757.84 million by 2032.
What is the CAGR of the Blood Transfusion Device Market during 2025–2032?
The market is expected to grow at a CAGR of 5.64%. This growth is measured over the period 2025 to 2032.
What is the largest product segment in 2025?
Blood bags & accessories is the largest product segment in 2025. The segment accounted for 37.4% share in 2025.
What factors are driving growth in the Blood Transfusion Device Market?
Growth is driven by rising transfusion-linked clinical workload and expanding surgical care access. Automation, standardization, and safety-focused procurement also strengthen demand.
Who are the leading companies in the Blood Transfusion Device Market?
Leading companies include Fresenius Kabi, Grifols, Terumo, BD, and Haemonetics. Other notable players include Teleflex, Baxter, B. Braun, and Immucor.
Which region leads the Blood Transfusion Device Market in 2025?
North America is the leading region in 2025. The region accounted for 39.3% share in 2025.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The global Brain Monitoring Market size was estimated at USD 7,112.2 million in 2025 and is expected to reach USD 10,694.12 million by 2032, growing at a CAGR of 6% from 2025 to 2032.
The global Bioimpedance Analyzers Market size was estimated at USD 880.14 million in 2025 and is expected to reach USD 2,282 million by 2032, growing at a CAGR of 14.58% from 2025 to 2032.
The global Bioactive Wound Dressing Market size was estimated at USD 5162.78 million in 2025 and is expected to reach USD 10254.45 million by 2032, growing at a CAGR of 10.3% from 2025 to 2032.
The global Autotransfusion Systems Market size was estimated at USD 528.39 million in 2025 and is expected to reach USD 796.6 million by 2032, growing at a CAGR of 6.04% from 2025 to 2032.
The Acoustic Neuroma Market is projected to grow from USD 4,634.09 million in 2025 to an estimated USD 7,638.26 million by 2032, with a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.
The Abdominal Aortic Aneurysm Repair Devices Market is projected to grow from USD 2803.7 million in 2025 to an estimated USD 4187.97 million by 2032, with a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.
The global Bone Densitometer Systems Market size was estimated at USD 362.51 million in 2025 and is expected to reach USD 477.04 million by 2032, growing at a CAGR of 4% from 2025 to 2032.
The global Brain PET-MRI Systems Market size was estimated at USD 410.35 million in 2025 and is expected to reach USD 604.89 million by 2032, growing at a CAGR of 5.7% from 2025 to 2032.
The global Brain Mapping Instruments Market size was estimated at USD 4587.09 million in 2025 and is expected to reach USD 8225.15 million by 2032, growing at a CAGR of 8.7% from 2025 to 2032.
The global Breast Cancer Screening Tests Market size was estimated at USD 4765.63 million in 2025 and is expected to reach USD 7572.83 million by 2032, growing at a CAGR of 6.84% from 2025 to 2032.
The global Bladder Scanners Market size was estimated at USD 495 million in 2025 and is expected to reach USD 797.47 million by 2032, growing at a CAGR of 7.05% from 2025 to 2032.
The global Biomedical Refrigerator & Freezer Market size was estimated at USD 4549.24 million in 2025 and is expected to reach USD 6908.42 million by 2032, growing at a CAGR of 6.15% from 2025 to 2032.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
